Article
Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset.
Journal of neuroimmunology - 15 Nov 2015
Wagner Marta, Sobczyński Maciej, Karabon Lidia, Bilińska Małgorzata, Pokryszko-Dragan Anna, Pawlak-Adamska Edyta, Cyrul Małgorzata, Kuśnierczyk Piotr, Jasek Monika
Abstract excerpt
CD28/CTLA-4–CD80/CD86 molecules play an important role in the regulation of T cells activation. Defects in proteins involved in this pathway may lead to the development of autoimmune diseases in which T cells are involved. In this case–control study (336 multiple sclerosis (MS) patients and 322 controls) we investigated the possible association of eleven polymorphisms in CD28, CTLA-4, CD80 and CD86 genes with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
